ArticleAdvances in virology2026
Molecular Characterization of Highly Pathogenic Marek's Disease Virus Strain in Vaccinated Iraqi Pullets.
Article in Advances in virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Molecular Characterization of Highly Pathogenic Marek's Disease Virus Strain in Vaccinated Iraqi Pullets.Advances in virology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Marek's disease (MD) remains a severe economic concern in poultry industry globally despite decades of vaccination strategies. Particularly challenging are viral infections due to Marek's disease virus (MDV) (Gallid alphaherpesvirus 2, GaHV-2) strains that can escape immune defenses in areas that do not have access to molecular surveillance data. Objective: This study performed molecular epidemiology of MDV in Iraqi commercial poultry based on extensive characterization of circulating strains, quantification of subclinical infection in vaccinated flocks, and phylogenetic sequencing to determine evolutionary relationships with local isolates. Materials and Methods: A cross-sectional surveillance on five commercial layer pullet flocks given the CVI988 vaccine took place from March to June 2024. A combined sample of 250 birds (50 birds per flock) was collected from Alrashdia in Baghdad Province. In this study, estimates were made for samples based on 5% expected prevalence, 95% confidence level, and 3% precision. Pulpy feather follicles and tissues were isolated for molecular detection of MDV meq oncogene by PCR amplification with known primers. Sanger sequencing was performed later and phylogenetic reconstruction carried out using the maximum likelihood technique. Results: Prevalence of subclinical MDV was 3.2% (8/250) in surveyed flocks, with significant operational heterogeneity (0%-6%). One flock had an acute clinical outbreak, and 86.7% of birds afflicted during the surveillance period showed paralysis. Molecular analysis revealed genetically homogeneous strain (Iraq/Baghdad/2024) with 99.8% nucleotide identity to Iranian very virulent isolates, with clustering in the very virulent pathotype clade and high bootstrap support (98%). Conclusion: This research describes the circulation of a very virulent, genetically uniform GaHV-2 strain capable of inducing vaccine breakthrough in Iraqi commercial poultry. The phylogenetic proximity to regional isolates suggests transboundary virus movement as a possible route of attack and highlights a gap in the level of molecular surveillance and optimization of Middle Eastern poultry production systems in immunization programs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.